Advances in Bispecific Antibodies in NHL: Practical Strategies for Oncology Pharmacists to Improve Patient Care

Gain expert-informed strategies for incorporating bispecific antibodies into the management of patients with non-Hodgkin lymphoma. Learn how to mitigate treatment-related adverse events to individualize and optimize therapy through a ClinicalThought commentary and downloadable slides.

Share

Program Content

Events

  • Live Event Advances in Bispecific Antibodies in NHL
    Advances in Bispecific Antibodies in NHL: Practical Strategies for Oncology Pharmacists to Improve Patient Care
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Bispecific Antibodies in NHL
Advances in Bispecific Antibodies in NHL: Practical Strategies for Oncology Pharmacists to Improve Patient Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 14, 2025

Expires: May 13, 2026

Provided by

ProCE Banner

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Genentech, a member of the Roche Group.

Genentech, a member of the Roche Group

Partners

Clinical Care Options, LLC

ProCE Banner